| Product NDC: | 0904-0734 |
| Proprietary Name: | TRIPLE ANTIBIOTIC |
| Non Proprietary Name: | bacitracin zinc neomycin sulfate polymyxin b sulfate |
| Active Ingredient(s): | 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g & nbsp; bacitracin zinc neomycin sulfate polymyxin b sulfate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0904-0734 |
| Labeler Name: | Major |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part333B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110601 |
| Package NDC: | 0904-0734-36 |
| Package Description: | 14 g in 1 TUBE (0904-0734-36) |
| NDC Code | 0904-0734-36 |
| Proprietary Name | TRIPLE ANTIBIOTIC |
| Package Description | 14 g in 1 TUBE (0904-0734-36) |
| Product NDC | 0904-0734 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | bacitracin zinc neomycin sulfate polymyxin b sulfate |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20110601 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Major |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Strength Number | 400; 3.5; 5000 |
| Strength Unit | [iU]/g; mg/g; [iU]/g |
| Pharmaceutical Classes |